HDL is the “good cholesterol” that helps remove fat from artery walls, reversing the process that leads to heart disease. Yet recent drug trials and genetic studies suggest that simply pushing HDL levels higher doesn’t necessarily reduce the risk of heart disease. Now, a team led by scientists from the Perelman School of Medicine at the University of Pennsylvania has shown in a large, forward-looking epidemiological study that a person’s HDL function—the efficiency of HDL molecules at removing cholesterol—may be a better measure of coronary heart disease risk and a better target for heart-protecting drugs.
Perelman School of Medicine
Attitudes about Complementary and Alternative Medicine Predict Use Among Cancer Patients, Penn's Abramson Cancer Center Finds
A cancer patient’s expectations about the benefits of complementary and alternative (CAM) and their perceived access to CAM therapies are likely to guide whether or not they will use those options, according to a new study published ahead of print in the journal CANCER from researchers at Abramson Cancer Center of the University of Pennsylvania.
Scott Lorch of the Perelman School of Medicine discusses potential risks to the practice of delayed umbilical cord clamping.
Jonathan Moreno of the Perelman School of Medicine and the School of Arts & Sciences writes about the characteristi
Gail Morrison of the Perelman School of Medicine and Mark Frazier Lloyd<
Steven Marcus of the Perelman School of Medicine and the School of Social Policy & Practice is cited for a collabor
Researchers from the Perelman School of Medicine at the University of Pennsylvania received a $400,000 grant from the Caring for Carcinoid Foundation (CFCF), a non-profit that funds research for carcinoid, pancreatic, and related neuroendocrine cancers (NETS), to investigate the use of an experimental gene therapy that engineers immune cells to attack cancers.
Kevin Volpp, MD, PhD, was presented with the 2015 Association for Clinical and Translational Science (ACTS) Distinguished Investigator Award for Career Achievement and Contribution to Clinical and Translational Science for translation from clinical use into public benefit and policy at the organization’s sixth annual meeting last month in Washington, D.C.
An important link between the human body clock and the immune system has relevance for better understanding inflammatory and infectious diseases, discovered collaborators at the Perelman School of Medicine at the University of Pennsylvania and Trinity College, Dublin.
It’s a long road from the University of Pennsylvania to Amsterdam, but cancer research knows no bounds.